Providing dermatologists with peer-reviewed, evidence-based information on the latest treatment options, new techniques, and practice management issues

CURRENT ISSUE—Vol. 10, No. 6 • June 2017

Letter to the Editor: Topical Anti-Estrogen Therapy To Treat Melasma

Letter to the Editor: Topical Anti-Estrogen Therapy To Treat Melasma

by Philip R. Cohen, MD Dear Editor: I read with interest the recent report by Snyder et al[1] describing melasma associated with the application of a topical estrogen cream. The development of melasma is multifactorial and female sex hormones have been implicated in the pathogenesis of this condition.[2] Estrogen receptor expression is increased in melasma […]

Continue Reading

The Burden of Illness of Erythe-matotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey

The Burden of Illness of Erythe-matotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey

aJames Q. Del Rosso, DO, FAOCD, FAAD; bEmil A. Tanghetti, MD; cHilary E. Baldwin, MD; dDavid A. Rodriguez, MD; eIlia L. Ferrusi, PhD aJDR Dermatology Research/Thomas Dermatology, Las Vegas, Nevada bThe Center for Dermatology and Laser Surgery, Sacramento, California cThe Acne Treatment and Research Center, Morristown, New Jersey dDermatology Associates and Research, Coral Gables, Florida; […]

Continue Reading

Treatment of Moderate-to-severe Acne Vulgaris in a Hispanic Population: A Post-hoc Analysis of the Efficacy and Tolerability of Clindamycin 1.2%/ Benzoyl Peroxide 3.75% Gel

Treatment of Moderate-to-severe Acne Vulgaris in a Hispanic Population: A Post-hoc Analysis of the Efficacy and Tolerability of Clindamycin 1.2%/ Benzoyl Peroxide 3.75% Gel

aAndrew F. Alexis, MD, MPH; bFran Cook-Bolden, MD; cTina Lin, PharmD aDepartment of Dermatology, Mount Sinai St. Luke’s and Mount Sinai West, New York, New York bSkin Specialty Dermatology and Department of Dermatology, Mount Sinai Health Systems, New York, New York cValeant Pharmaceuticals North America LLC, Bridgewater, New Jersey Disclosure: Dr. Alexis is an Advisory […]

Continue Reading

Treatment of Actinic Purpura

Treatment of Actinic Purpura

Roger I. Ceilley, MD Dermatology PC, West Des Moines, Iowa Disclosure: The author acknowledges the editorial assistance of Dr. Carl S. Hornfeldt, Apothekon, Inc., with funding provided by Ferndale Healthcare. Abstract Mature skin is prone to bruising, resulting in a condition known as actinic purpura, characterized by unsightly ecchymosis and purple patches. Similar to other […]

Continue Reading

Nonablative Fractional Laser Resurfacing in Skin of Color: Evidence-based Review

Nonablative Fractional Laser Resurfacing in Skin of Color: Evidence-based Review

Shivani B. Kaushik, MD; Andrew F. Alexis, MD, MPH Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York Disclosure: The authors report no relevant conflicts of interest. Abstract Background: Nonablative laser resurfacing represents one of the major advances in procedural dermatology over the past decade. However, its use in darker […]

Continue Reading

PAST ARTICLES

Psychosocial Impact of Postinflammatory Hyperpigmentation in Patients with Acne Vulgaris

Psychosocial Impact of Postinflammatory Hyperpigmentation in Patients with Acne Vulgaris

aKavita Darji, MD; bReena Varade, MD; bDaniel West, MD; cEric S. Armbrecht, PhD; bMary A. Guo, MD aSaint Louis University School of Medicine, Saint Louis, Missouri bDepartment of Dermatology, Saint Louis University School of Medicine, Saint Louis, Missouri cCenter for Health Outcomes Research, Saint Louis University, Saint Louis, Missouri Disclosure: The authors report no relevant […]

Continue Reading

A Retrospective Study of Non-thermal Laser Therapy for the Treatment of Toenail Onychomycosis

A Retrospective Study of Non-thermal Laser Therapy for the Treatment of Toenail Onychomycosis

aKerry Zang, DPM; bRobert Sullivan, BSc (Hons) Podiatry, MSc Pod Surgery, PgCAcup, FIChPA, MInstChP; cSteven Shanks aArizona Institute of Footcare Physicians, Mesa, Arizona bMidleton Foot Clinic Group, Midleton, County Cork, Ireland cErchonia Corporation, Melbourne, Florida Disclosure: Dr. Zang reports no relevant conflicts of interest. Mr. Shanks is employed by Erchonia Corporation. This study was sponsored […]

Continue Reading

A Prospective, Randomized, Double-blind, Split-face Clinical Trial Comparing the Efficacy of Two  Topical Human Growth Factors  for the Rejuvenation of the Aging Face

A Prospective, Randomized, Double-blind, Split-face Clinical Trial Comparing the Efficacy of Two Topical Human Growth Factors for the Rejuvenation of the Aging Face

Douglas C. Wu, MD, PhD; Mitchel P. Goldman, MD Cosmetic Laser Dermatology, San Diego, California Disclosure: Dr. Wu reports no relevant conflicts of interest. Dr. Goldman is a consultant for Nuderm and SkinMedica. The study was funded by Nuderm. Abstract Background: Cosmeceutical products represent an increasingly important therapeutic option for anti-aging and rejuvenation, either used […]

Continue Reading

Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure

Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure

aAaron Tabor, MD; bJoseph V. Pergolizzi, Jr., MD; cGuy Marti, MD; cJohn Harmon, MD; dBernard Cohen, MD; aJo Ann LeQuang, BA aGenArmor, Winston-Salem, North Carolina; bNEMA Research, Inc, Naples, Florida; cDepartment of Surgery and Hendrix Burn/Wound Laboratory, Johns Hopkins University School of Medicine, Baltimore, Maryland; dDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, […]

Continue Reading

Aesthetic Treatment of Bruxism

Aesthetic Treatment of Bruxism

aShino Bay Aguilera, DO, FAOCD; bLiza Brown, DO; cViviana Andrea Perico, MD aVolunteer Professor, Nova Southeastern University College of Osteopathic Medicine, Department of Dermatology, Fort Lauderdale, Florida bDermatology Resident—PGY3, Larkin Community Hospital, Miami, Florida cThird Year Aesthetic Medicine Resident, Rosario University, Bogota, Colombia Disclosure: The authors report no relevant conflicts of interest.  Abstract Bruxism is […]

Continue Reading

Recent Posts

Letter to the Editor: Topical Anti-Estrogen Therapy To Treat Melasma

Letter to the Editor: Topical Anti-Estrogen Therapy To Treat Melasma

| June 1, 2017

by Philip R. Cohen, MD Dear Editor: I read with interest the recent report by Snyder et al[1] describing melasma associated with the application of a topical estrogen cream. The development of melasma is multifactorial and female sex hormones have been implicated in the pathogenesis of this condition.[2] Estrogen receptor expression is increased in melasma […]

Continue Reading

The Burden of Illness of Erythe-matotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey

The Burden of Illness of Erythe-matotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey

| June 1, 2017

aJames Q. Del Rosso, DO, FAOCD, FAAD; bEmil A. Tanghetti, MD; cHilary E. Baldwin, MD; dDavid A. Rodriguez, MD; eIlia L. Ferrusi, PhD aJDR Dermatology Research/Thomas Dermatology, Las Vegas, Nevada bThe Center for Dermatology and Laser Surgery, Sacramento, California cThe Acne Treatment and Research Center, Morristown, New Jersey dDermatology Associates and Research, Coral Gables, Florida; […]

Continue Reading

Treatment of Moderate-to-severe Acne Vulgaris in a Hispanic Population: A Post-hoc Analysis of the Efficacy and Tolerability of Clindamycin 1.2%/ Benzoyl Peroxide 3.75% Gel

Treatment of Moderate-to-severe Acne Vulgaris in a Hispanic Population: A Post-hoc Analysis of the Efficacy and Tolerability of Clindamycin 1.2%/ Benzoyl Peroxide 3.75% Gel

| June 1, 2017

aAndrew F. Alexis, MD, MPH; bFran Cook-Bolden, MD; cTina Lin, PharmD aDepartment of Dermatology, Mount Sinai St. Luke’s and Mount Sinai West, New York, New York bSkin Specialty Dermatology and Department of Dermatology, Mount Sinai Health Systems, New York, New York cValeant Pharmaceuticals North America LLC, Bridgewater, New Jersey Disclosure: Dr. Alexis is an Advisory […]

Continue Reading

Treatment of Actinic Purpura

Treatment of Actinic Purpura

| June 1, 2017

Roger I. Ceilley, MD Dermatology PC, West Des Moines, Iowa Disclosure: The author acknowledges the editorial assistance of Dr. Carl S. Hornfeldt, Apothekon, Inc., with funding provided by Ferndale Healthcare. Abstract Mature skin is prone to bruising, resulting in a condition known as actinic purpura, characterized by unsightly ecchymosis and purple patches. Similar to other […]

Continue Reading

Nonablative Fractional Laser Resurfacing in Skin of Color: Evidence-based Review

Nonablative Fractional Laser Resurfacing in Skin of Color: Evidence-based Review

| June 1, 2017

Shivani B. Kaushik, MD; Andrew F. Alexis, MD, MPH Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York Disclosure: The authors report no relevant conflicts of interest. Abstract Background: Nonablative laser resurfacing represents one of the major advances in procedural dermatology over the past decade. However, its use in darker […]

Continue Reading

Psychosocial Impact of Postinflammatory Hyperpigmentation in Patients with Acne Vulgaris

Psychosocial Impact of Postinflammatory Hyperpigmentation in Patients with Acne Vulgaris

| May 1, 2017

aKavita Darji, MD; bReena Varade, MD; bDaniel West, MD; cEric S. Armbrecht, PhD; bMary A. Guo, MD aSaint Louis University School of Medicine, Saint Louis, Missouri bDepartment of Dermatology, Saint Louis University School of Medicine, Saint Louis, Missouri cCenter for Health Outcomes Research, Saint Louis University, Saint Louis, Missouri Disclosure: The authors report no relevant […]

Continue Reading